It’s getting harder to ignore cannabidiol (CBD), the miracle compound that’s extracted from the cannabis plant. Over the years, plenty of anecdotal evidence has surfaced, claiming that the compound is effective against a score of diseases, ranging from mild conditions like anxiety and insomnia to more severe ones like epilepsy and chronic pain. It has become more accessible than it ever was, with plenty of retailers and pharmacies offering CBD-infused products to cater to the massive demand for the substance.
Recently, a study presented at the Anesthesiology annual meeting found that unlike drugs such as alcohol and cigarettes, most women of childbearing age were not afraid of any health ramifications from using CBD products during pregnancy. Researchers surveyed women aged 18 – 44, physician anesthesiologists, certified nurse-midwives, and…
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com